Thomas Gajewski to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications Thomas Gajewski has written about Vascular Endothelial Growth Factor A.
Connection Strength
0.214
-
A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma. Invest New Drugs. 2016 Apr; 34(2):231-5.
Score: 0.105
-
Melanoma presenting as circulating tumor cells associated with failed angiogenesis. Melanoma Res. 2008 Aug; 18(4):289-94.
Score: 0.062
-
Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):4048-54.
Score: 0.047